Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2014
08/06/2014CN102046651B 短螺旋体的新序列、免疫原性组合物、制备方法及其用途 Brachyspira new sequence, the immunogenic composition, preparation and use
08/06/2014CN101970006B α5-β1抗体和它们的用途 α5-β1 antibody and uses thereof
08/06/2014CN101802012B 抗cd79b抗体和免疫偶联物及使用方法 Anti cd79b antibodies and immune conjugates and method of use
08/06/2014CN101670105B 螯合淀粉样蛋白β肽的人源化抗体 Human amyloid β peptide chelating humanized antibody
08/06/2014CN101495513B 促血管生成素-2特异性结合剂 Angiopoietin-2 specific binding agents
08/06/2014CN101107009B 包含纤连蛋白结合蛋白或纤连蛋白结合肽的疫苗组合物 Vaccine compositions containing fibronectin-binding protein or fibronectin-binding peptides
08/05/2014US8798933 Frozen compositions and methods for piercing a substrate
08/05/2014US8798932 Frozen compositions and methods for piercing a substrate
08/05/2014US8796235 Methods for attenuating dengue virus infection
08/05/2014US8796227 Peptides for inhibiting chemokine binding to chemokine receptors
08/05/2014US8796220 Vaccine for the prevention of the recurrence HER2/neu expressing cancer
08/05/2014US8796013 Pre-or post-exposure treatment for filovirus or arenavirus infection
08/05/2014US8795734 Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells
08/05/2014US8795719 Immunotherapeutic agent suitable for the primary prophylaxis of tuberculosis
08/05/2014US8795691 Nanotubes and compositions thereof
08/05/2014US8795690 Protective proteins of S. agalactiae, combinations thereof and methods of using the same
08/05/2014US8795689 Method for controlling Streptococcus pneumoniae serotype 19A polysaccharide molecular weight
08/05/2014US8795688 Dengue serotype 2 attenuated strain
08/05/2014US8795687 West Nile virus prM-E signal peptide facilitating the efficient assembly, maturation, and release of virus-like particles (VLPs)
08/05/2014US8795686 Stable, dried rotavirus vaccine, compositions and process for preparation thereof
08/05/2014US8795685 Mutated HIV Nef for modulating immunity
08/05/2014US8795684 Agent for use in the topical or local treatment of cervical dysplasias
08/05/2014US8795683 Vaccine formulations and uses thereof
08/05/2014US8795682 Virus-like particles comprising chimeric human immunodeficiency virus (HIV)/mouse mammary tumor virus (MMTV) envelopes
08/05/2014US8795681 Raccoon poxvirus expressing rabies glycoproteins
08/05/2014US8795680 Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-D-manno-octulsonic acid
08/05/2014US8795678 TLR-2 agonists and methods of use thereof
08/05/2014US8795677 Treatment methods using an F1-V plague vaccine
08/05/2014US8795676 Genes encoding major capsid protein L1 of human papilloma virus
08/05/2014US8795675 Allergy inhibitor compositions and kits and methods of using the same
08/05/2014US8795674 Methods and compositions for modulating immune tolerance
08/05/2014US8795673 Preparation of maytansinoid antibody conjugates by a one-step process
08/05/2014US8795672 Compositions and methods for cancer immunotherapy
08/05/2014US8795671 Subcutaneous administration of anti-hepatitis B antibodies
08/05/2014US8795670 Formulation of human antibodies for treating TNF-alpha associated disorders
08/05/2014US8795669 Stabilized formulations containing anti-PCSK9 antibodies
08/05/2014US8795668 Methods for treating pulmonary fibrosis
08/05/2014US8795667 Compositions for the prevention and treatment of smallpox
08/05/2014US8795666 Antagonists of IL-23P19 for treatement of atopic dermatitis
08/05/2014US8795665 BMP-6 antibodies
08/05/2014US8795664 Monoclonal antibodies targeting amyloid beta oligomers
08/05/2014US8795663 Soluble endoglin and uses thereof
08/05/2014US8795662 Anti-mucin antibodies for early detection and treatment of pancreatic cancer
08/05/2014US8795661 Molecules with extended half-lives, compositions and uses thereof
08/05/2014US8795660 Neuropilin antagonists
08/05/2014US8795659 Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
08/05/2014US8795658 Stabilization of immunoglobulins through aqueous formulation with histidine at weak acidic to neutral pH
08/05/2014US8795657 Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition
08/05/2014US8795656 Methods of treating rheumatoid arthritis by administering an anti-IL3 antibody
08/05/2014US8795653 Methods for repressing B cell autoantibody secretion and for treating autoimmune disorders by administration of hematopoietic stem cells and macrophage-colony stimulating factor
08/05/2014US8795634 Absorption of therapeutic agents across mucosal membranes or the skin
08/05/2014CA2841016A1 Wt1 peptide cancer vaccine composition for transdermal administration
08/05/2014CA2841014A1 Tape preparation of wt1 peptide cancer vaccine for transdermal administration
08/05/2014CA2840997A1 Vaccine composition for transdermal administration
08/05/2014CA2840988A1 Wt1 peptide cancer vaccine composition for mucosal administration
08/05/2014CA2840978A1 Vaccine composition for mucosal administration
08/05/2014CA2840974A1 Vaccine composition for mucosal administration
08/05/2014CA2840959A1 Vaccine composition
08/05/2014CA2840954A1 Vaccine composition for transdermal or mucosal administration
08/05/2014CA2840941A1 Wt1 peptide cancer vaccine composition for transdermal administration
08/05/2014CA2840937A1 Vaccine composition for transdermal administration
08/05/2014CA2754113C Alpha-4-beta-7 heterodimer specific antagonist antibody
08/05/2014CA2740248C Nicotine immunonanotherapeutics
08/05/2014CA2736972C Tumour-associated peptides that bind to mhc molecules
08/05/2014CA2649269C Protein complex and process for producing the same
08/05/2014CA2609269C Humanized anti-cd40 antibodies and their methods of use
08/05/2014CA2581840C Optimized vaccines to provide protection against ebola and other viruses
08/05/2014CA2559996C Combination vaccines with low dose of hib conjugate
08/05/2014CA2555390C Immunostimulatory viral rna oligonucleotides
08/05/2014CA2507115C Treatment of mammalian reaction to ige interactions
08/05/2014CA2505316C Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
08/05/2014CA2466431C Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
08/05/2014CA2465325C Antibodies for inhibiting blood coagulation and methods of use thereof
08/05/2014CA2461351C Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells
08/05/2014CA2457140C Beta-amyloid-analogue - t-cell epitope vaccine
08/05/2014CA2430972C Fibrin fragments for treating inflammation
08/05/2014CA2376923C Prevention of type 1 diabetes and other non-polio enterovirus diseases
08/05/2014CA2347099C Adjuvant systems comprising an immunostimulant adsorbed to a metallic salt particle and vaccines thereof
07/2014
07/31/2014WO2014117185A1 Rift valley fever virus glycoproteins, gn and gc, and their use
07/31/2014WO2014117160A1 Anti-flt-1 antibodies in treating duchenne muscular dystrophy
07/31/2014WO2014117148A1 Treatment methods using atoxic neurotoxin derivatives
07/31/2014WO2014117089A1 Compositions and methods for the treatment of pervasive development disorders
07/31/2014WO2014117053A1 Anti-angiogenic vegf-ax isoform
07/31/2014WO2014116996A1 Derivatives of fatty esters, fatty acids and rosins
07/31/2014WO2014116990A1 Genetic attenuation of plasmodium by b9 gene disruption
07/31/2014WO2014116880A1 Targeting constructs based on natural antibodies and uses thereof
07/31/2014WO2014116789A1 Immunogenic and prophylactic compositions, methods of making same, and method for treating and preventing tnf-mediated disease and hiv-1 infection
07/31/2014WO2014116749A1 Anti-hcv antibodies and methods of using thereof
07/31/2014WO2014116596A1 Methods for optimizing domain stability of binding proteins
07/31/2014WO2014116587A1 Stimulation of vaccination by angiotensin peptides
07/31/2014WO2014116184A1 Angiopoietin-related protein 4 (cangptl4) as a diagnostic biomarker for acute lung damage
07/31/2014WO2014115104A1 Influenza virus reassortment
07/31/2014WO2014114926A1 Glycoconjugate vaccines
07/31/2014WO2014114812A1 A single or multistage mycobacterium avium subsp. paratuberculosis subunit vaccine
07/31/2014WO2014114800A1 Antibody constructs for cdh19 and cd3
07/31/2014WO2014114691A1 Use of replication deficient hsv-1 as a vaccine vector for the deli vary of hiv-1 tat antigen
07/31/2014WO2014114651A1 Tnf-alpha antigen-binding proteins
07/31/2014WO2014114298A1 Mfap4 binding antibodies blocking the interaction between mfap4 and integrin receptors
07/31/2014WO2014106116A3 Therapeutic compositions comprising antibodies
07/31/2014WO2014093894A3 Dna antibody constructs and method of using same
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 1823